The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | J | Antiinfectives for systemic use | |
2 | J06 | Immune sera and immunoglobulins | |
3 | J06B | Immunoglobulins | |
4 | J06BB | Specific immunoglobulins |
Code | Title | |
---|---|---|
J06BB01 | Anti-D (rh) immunoglobulin | |
J06BB02 | Tetanus immunoglobulin | |
J06BB03 | Varicella/zoster immunoglobulin | |
J06BB04 | Hepatitis B immunoglobulin | |
J06BB05 | Rabies immunoglobulin | |
J06BB06 | Rubella immunoglobulin | |
J06BB07 | Vaccinia immunoglobulin | |
J06BB08 | Staphylococcus immunoglobulin | |
J06BB09 | Cytomegalovirus immunoglobulin | |
J06BB10 | Diphtheria immunoglobulin | |
J06BB11 | Hepatitis A immunoglobulin | |
J06BB12 | Encephalitis, tick borne immunoglobulin | |
J06BB13 | Pertussis immunoglobulin | |
J06BB14 | Measles immunoglobulin | |
J06BB15 | Mumps immunoglobulin | |
J06BB19 | ||
J06BB30 | Combinations |
Active Ingredient | Description | |
---|---|---|
Anthrax immunoglobulin |
Anthrax immuneglobulin is a human immune globulin that is used in combination with antibiotics to treat anthrax. Anthrax immunoglobulin binds to protective antigen (PA) to prevent PA mediated cellular entry of anthrax edema factor and lethal factor. |
|
Anti-D (rh) immunoglobulin |
Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known. |
|
Cytomegalovirus immunoglobulin |
Cytomegalovirus immunoglobulin is used as a CMV-specific polyclonal immunoglobulin preparation that binds to CMV surface antigens thereby neutralizing the potential of CMV from entering host cells and presenting the CMV particle for phagocytosis. Furthermore, cytomegalovirus immunoglobulin can activate CMV-reactive immune cells for long-lasting CMV-specific immune responses. |
|
Human hepatitis B immunoglobulin |
Human hepatitis B immunoglobulin solution for infusion contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against hepatitis B virus surface antigen (HBs). It is used for the immunoprophylaxis of hepatitis B and the prevention of hepatitis B virus re-infection after liver transplantation for hepatitis B induced liver failure. |
|
Human antimeasles immunoglobulin |
|
|
Human rabies immunoglobulin |
Human rabies immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against rabies virus. Human Rabies Immunoglobulin must always be used in combination with a rabies vaccine. |
|
Human varicela zoster immunoglobulin |
Human varicella zoster immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against varicella-zoster virus. It is used for prophylaxis against varicella zoster virus (VZV) infection. |
|
Pertussis filamentous hemagglutinin |
|
|
Tetanus immunoglobulin |
Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus. |
|
Vaccinia immunoglobulin |
Vaccinia immunoglobulin provides passive immunity for individuals with complications to vaccinia virus vaccination. The exact mechanism of action is not known. |
Title | Information Source | Document Type | |
---|---|---|---|
CYTOGAM Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
CYTOTECT CP BIOTEST Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
HEPAGAM B Solution for infusion | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
HEPATECT CP Solution for infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
HYPERHEP B Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
HYPERRAB Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
HYPERRHO S/D FULL DOSE Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
HYPERTET Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
RHESONATIV Solution for injection | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
RHOPHYLAC Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
TETAGAM-P Solution for injection | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
VARIZIG Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
WINRHO SDF Solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
ZUTECTRA Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |